Abdulla A. Damluji/Linkedin
Aug 12, 2025, 20:14
JACC Meta-Analysis: Anticoagulant Therapy for Atrial Fibrillation Patients Surviving Intracranial Hemorrhage
Abdulla A. Damluji, Director of the Cardiovascular Center on Aging at Cleveland Clinic, has shared a post on X:
“Anticoagulants for Atrial Fibrillation in Survivors of Intracranial Hemorrhage: A Meta-Analysis of Randomized Trials: JACCJournals.
New publication from our HeartWise research Group led by friend: Michael Nanna in JACC today!”
Read the full article here.
Title: Anticoagulants for Atrial Fibrillation in Survivors of Intracranial Hemorrhage
Authors: Kuan-Yu Chi, Yu Chang, Pei-Lun Lee, Raiza Rossi, Yu-Shiuan Lin, Zafer Akman, Dimitrios Varrias, Abdulla A. Damluji, and Michael G. Nanna
Stay updated on the latest scientific advances in the field of bleeding disorders with Hemostasis Today.
-
Nov 19, 2025, 18:03Andres Ricaurte Fajardo on a Strongyloides Stercoralis Hyperinfection with Thrombosis
-
Nov 19, 2025, 17:50Marilena Vrana Reflects on PPTA Europe’s Visits with Members and Stakeholders in 2025
-
Nov 19, 2025, 17:32Michael Makris Shares Insights from Global Forum Meeting of the WFH Meeting in Montreal
-
Nov 19, 2025, 17:14Yazan Abou Ismail Takes The Legacy Award from Qatar Foundation
-
Nov 19, 2025, 17:02Wolfgang Miesbach Shares Real-World Evidence on Eptacog Beta from Spain
-
Nov 19, 2025, 16:34Ishita Singh Reflects on Haematocon 2025: A Reminder of Her Commitment to The Journey
-
Nov 19, 2025, 16:23Mehdi Kashani: I’m Really Excited to Share Schistosite.com
-
Nov 19, 2025, 16:09A ”Meow-cyte” from Melaku Abay Muluneh or Why Microscopy Never Gets Old!
-
Nov 19, 2025, 15:56Cuilan Li on her Contribution to a Cutting-Edge Project in Polycythemia Vera